转染试剂与设备市场报告：2031 年趋势、预测与竞争分析

由于学术和研究机构以及製药和生物技术公司市场存在机会，全球转染试剂和设备市场的未来前景光明。预计到 2031 年，全球转染试剂和设备市场规模将达到 21 亿美元，2025 年至 2031 年的复合年增长率为 6.5%。该市场的主要驱动力是全球慢性病负担的增加、对合成基因的高需求以及转染技术的进步。

• 根据 Lucintel 的预测，随着主要企业推出多种产品来扩大其试剂组合，试剂有望在预测期内实现高成长。
• 根据最终用途，由于全球疾病负担的增加以及试剂和设备的采用率的提高，製药和生物技术公司可能继续成为最大的细分市场。
• 从地区来看，预计北美将在预测期内继续成为最大的地区，这得益于基因组学研发投资的增加、蛋白质疗法的需求的不断增长以及该地区主要参与者的存在。

转染试剂和设备市场的策略性成长机会

转染试剂和设备市场有几个策略性成长机会：

• 基因治疗：转染技术在基因治疗中的应用日益广泛，这提供了巨大的成长机会，因为它增强了治疗基因的传递并改善了治疗结果。
• 药物发现：快速研究基因功能和药物交互作用将加速开发新药。
• 癌症研究：增强的基因传递方法对于癌症研究至关重要，可以改善与癌症相关的基因和治疗标靶的研究。
• 再生医学：转染技术对于再生医学新治疗方法的开发至关重要，并有助于组织工程和干细胞研究的进步。
• 农业生物技术：转染技术在农业生物技术中的潜力巨大，有助于开发基因改造作物，提高食品安全和农业生产力。

这些成长机会正在推动转染技术应用在各个领域的扩展，从而推动市场成长和创新。

转染试剂和设备市场驱动因素与挑战

影响转染试剂和设备市场的因素很多，包括技术、经济和监管。以下是关键驱动因素和挑战的分析：

推动转染试剂和设备市场发展的因素包括：

• 技术进步：奈米粒子和自动化等技术创新改善了基因传递，透过提高效率和效力来推动市场成长。
• 增加研究投入：增加对生物技术和基因组学研究的投资将推动对先进转染技术的需求，从而扩大市场。
• 基因治疗需求不断增长：基因治疗应用的不断扩大推动了对有效转染技术的需求，从而推动了市场成长。
• 个人化医疗：个人化医疗的兴起要求转染技术能够针对每位患者进行量身定制，进一步增加了对客製化解决方案的需求。

转染试剂和设备市场的挑战是：

• 高成本：先进的转染试剂和设备的成本可能成为使用的障碍，特别是对于发展中地区的小型研究机构。
• 技术复杂性：新转染技术的复杂性可能为使用者培训和融入现有工作流程带来挑战。

这些市场驱动因素和挑战正在塑造转染试剂和设备市场，并影响产业的成长模式和策略决策。

目录

第一章执行摘要

第二章全球转染试剂与设备市场：市场动态

• 简介、背景和分类
• 供应链
• 产业驱动力与挑战

第三章市场趋势与预测分析（2019-2031）

• 宏观经济趋势（2019-2024）及预测（2025-2031）
• 全球转染试剂及设备市场趋势（2019-2024）及预测（2025-2031）
• 全球转染试剂和设备市场（按产品）
  • 试剂
  • 装置
• 全球转染试剂和设备市场（依方法）
  • 物理方法
  • 生化方法
  • 病毒方法
• 全球转染试剂和设备市场（按应用）
  • 蛋白质生产
  • 生物医学研究
  • 治疗实施
• 全球转染试剂和设备市场（依最终用途）
  • 学术和研究机构
  • 製药和生物技术公司
  • 其他的

第四章区域市场趋势与预测分析（2019-2031）

• 全球转染试剂和设备市场（按地区）
• 北美转染试剂与设备市场
• 欧洲转染试剂与设备市场
• 亚太转染试剂与设备市场
• 世界其他地区的转染试剂和设备市场

第五章 竞争分析

• 产品系列分析
• 营运整合
• 波特五力分析

第六章 成长机会与策略分析

• 成长机会分析
  • 全球转染试剂和设备市场成长机会（按产品）
  • 全球转染试剂和设备市场成长机会（按方法）
  • 全球转染试剂和设备市场的成长机会（按应用）
  • 全球转染试剂和设备市场成长机会（以最终用途）
  • 全球转染试剂和设备市场各区域成长机会
• 全球转染试剂和设备市场的新趋势
• 战略分析
  • 新产品开发
  • 扩大全球转染试剂和设备市场的产能
  • 全球转染试剂和设备市场的企业合併
  • 认证和许可

第七章主要企业简介

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen NV
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

The future of the global transfection reagent and equipment market looks promising with opportunities in the academic & research institute and pharmaceutical & biotechnology company markets. The global transfection reagent and equipment market is expected to reach an estimated $2.1 billion by 2031 with a CAGR of 6.5% from 2025 to 2031. The major drivers for this market are the increasing burden of chronic diseases across the globe, high demand for synthetic genes, and technological advancements in transfection.

• Lucintel forecasts that, within the product category, the reagent is expected to witness higher growth over the forecast period due to a huge number of launches by key players to broaden their reagents portfolio.
• Within the end use category, pharmaceutical & biotechnology companies will remain the largest segment due to increasing burden of diseases and rising adoption of reagent and equipment worldwide.
• In terms of regions, North America will remain the largest segment over the forecast period due to rising investments in research and development in genomics, growing demand for protein therapeutics, and the existence of major players in the region.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is evolving with several notable trends:

• Nanoparticle-Based Reagents: These reagents are becoming popular due to their effectiveness in gene delivery with minimal cytotoxicity. Their superior stability and targeting capabilities lead to higher success rates in transfection.
• Transfection Automation: Automation technologies facilitate high-throughput screening, reducing manual intervention. Automated systems enhance reproducibility and efficiency, supporting extensive research and therapeutic applications.
• Advanced Electroporation Systems: New developments in electroporation technology improve the precision and efficiency of gene delivery, enhancing the intracellular delivery of nucleic acids for gene therapy and genetic research.
• Integration with Gene Editing Tools: The merging of transfection technologies with tools like CRISPR/Cas9 is gaining traction, increasing the efficiency and specificity of genetic modifications.
• Applications in Personalized Medicine: Transfection technologies are increasingly tailored to individual genetic backgrounds, enhancing their effectiveness in gene therapies and targeted treatments.

These trends are driving innovation and expanding the applications of transfection reagents and equipment, thereby improving research and therapeutic development prospects.

Recent Developments in the Transfection Reagent and Equipment Market

Key developments in the transfection reagent and equipment market include:

• Nanoparticle Innovations: Advanced nanoparticle-based transfection reagents are enhancing gene delivery efficiency while reducing cytotoxicity, making them suitable for diverse research and therapeutic applications.
• High-Throughput Systems: The introduction of high-throughput transfection systems is streamlining workflows and increasing productivity in genomic research by enabling simultaneous processing of multiple samples.
• Cost-Effective Solutions: The design of novel, affordable reagents and equipment is making advanced transfection technologies more accessible, especially in developing regions, thus enhancing global research and development.
• Electroporation Technologies: New electroporation systems offer improved control over gene delivery accuracy and efficiency, expanding applications in gene therapy and cellular research.
• Integration with Advanced Technologies: The latest transfection technologies are increasingly integrated with advanced tools like CRISPR/Cas9, facilitating precise genetic alterations and innovative therapeutic approaches.

These developments are propelling the field towards more efficient, accessible, and precise applications.

Strategic Growth Opportunities for Transfection Reagent and Equipment Market

Several strategic growth opportunities exist within the transfection reagent and equipment market:

• Gene Therapy: The growing use of transfection technologies in gene therapy presents significant growth opportunities, enhancing the delivery of therapeutic genes and improving treatment outcomes.
• Drug Discovery: Transfection technologies are becoming essential in drug discovery processes, enabling rapid studies of gene function and drug interactions, thus accelerating new drug development.
• Cancer Research: Enhanced methodologies for gene delivery are crucial for cancer research, improving the study of cancer-related genes and therapeutic targets.
• Regenerative Medicine: Transfection technologies are vital in developing new treatments within regenerative medicine, contributing to advancements in tissue engineering and stem cell research.
• Agricultural Biotechnology: There is significant potential for transfection technologies in agricultural biotechnology, aiding in the development of genetically modified crops for enhanced food safety and agricultural productivity.

These growth opportunities are expanding the application of transfection technologies across various sectors, driving market growth and innovation.

Transfection Reagent and Equipment Market Driver and Challenges

The various factors affecting the transfection reagent and equipment market include technological, economic, and regulatory. Below is an analysis of major drivers and challenges:

The factors responsible for driving the transfection reagent and equipment market include:

• Technological Advancements: Innovations like nanoparticles and automation improve gene delivery, driving market growth through enhanced efficiency and effectiveness.
• Increased Research Investments: Growing investments in biotechnology and genomic research are boosting demand for advanced transfection technologies, leading to market expansion.
• Rising Demand for Gene Therapies: The expanding applications of gene therapy create a heightened need for effective transfection technologies, catalyzing market growth.
• Personalized Medicine: The advancement of personalized medicine necessitates tailored transfection techniques, further driving demand for customized solutions.

Challenges in the transfection reagent and equipment market are:

• High Costs: The expense of sophisticated transfection reagents and equipment can deter use, particularly in smaller research facilities in developing regions.
• Complexity of Technologies: The sophistication of new transfection technologies can present challenges in user training and integration into existing workflows.

These drivers and challenges shape the transfection reagent and equipment market, influencing growth patterns and strategic decisions within the industry.

List of Transfection Reagent and Equipment Companies

Companies in the market compete based on product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies transfection reagents and equipment companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the transfection reagent and equipment companies profiled in this report include-

• PromoCell
• OriGene Technologies
• Thermos Fisher Scientific
• Merck
• Bio-Rad Laboratories
• Lonza
• Qiagen N.V.
• Mirus Bio
• Promega Corporation
• F. Hoffmann-La Roche

Transfection Reagent and Equipment by Segment

The study includes a forecast for the global transfection reagent and equipment market by product, method, application, end use, and region.

Transfection Reagent and Equipment Market by Product [Analysis by Value from 2019 to 2031]:

• Reagents
• Equipment

Transfection Reagent and Equipment Market by Method [Analysis by Value from 2019 to 2031]:

• Physical Methods
• Biochemical Methods
• Viral Methods

Transfection Reagent and Equipment Market by Application [Analysis by Value from 2019 to 2031]:

• Protein Production
• Biomedical Research
• Therapeutic Delivery

Transfection Reagent and Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Academics & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

Transfection Reagent and Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Transfection Reagent and Equipment Market

The transfection reagents and equipment market is rapidly evolving, driven by continuous technological advancements and expanding applications in research and therapeutics. Recent developments in key markets include:

• United States: The U.S. market is experiencing significant growth due to advancements in nanoparticle-based transfection reagents and electroporation equipment, improving gene delivery efficiency for research and therapeutic applications.
• China: Increased domestic production of affordable reagents and equipment is fostering growth in China, enhancing accessibility for local researchers and biotech firms.
• Germany: Ongoing development of high-throughput transfection systems and reagents in Germany is improving workflow efficiency in genomic research and pharmaceutical development.
• India: Investment in biotechnology research and development is driving growth in transfection technologies, with initiatives focused on creating affordable and scalable solutions.
• Japan: Japan is prioritizing the integration of microfluidics and gene editing tools in transfection systems, enhancing precision and efficiency in gene delivery for various applications.

Features of the Global Transfection Reagent and Equipment Market

Market Size Estimates: Transfection reagent and equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Transfection reagent and equipment market size by various segments, such as by product, method, application, end use, and region in terms of value ($B).

Regional Analysis: Transfection reagent and equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different products, methods, applications, end uses, and regions for the transfection reagent and equipment market.

Strategic Analysis: This includes M&A, new product development, and the competitive landscape of the transfection reagent and equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M&A, and more.

This report answers the following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the transfection reagent and equipment market by product (reagents and equipment), method (physical methods, biochemical methods, and viral methods), application (protein production, biomedical research, and therapeutic delivery), end use (academics & research institutes, pharmaceutical & biotechnology companies, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Transfection Reagent and Equipment Market : Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Transfection Reagent and Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Transfection Reagent and Equipment Market by Product
  • 3.3.1: Reagents
  • 3.3.2: Equipment
• 3.4: Global Transfection Reagent and Equipment Market by Method
  • 3.4.1: Physical Methods
  • 3.4.2: Biochemical Methods
  • 3.4.3: Viral Methods
• 3.5: Global Transfection Reagent and Equipment Market by Application
  • 3.5.1: Protein Production
  • 3.5.2: Biomedical Research
  • 3.5.3: Therapeutic Delivery
• 3.6: Global Transfection Reagent and Equipment Market by End Use
  • 3.6.1: Academics & Research Institutes
  • 3.6.2: Pharmaceutical & Biotechnology Companies
  • 3.6.3: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Transfection Reagent and Equipment Market by Region
• 4.2: North American Transfection Reagent and Equipment Market
  • 4.2.1: North American Market by Product: Reagents and Equipment
  • 4.2.2: North American Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.3: European Transfection Reagent and Equipment Market
  • 4.3.1: European Market by Product: Reagents and Equipment
  • 4.3.2: European Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.4: APAC Transfection Reagent and Equipment Market
  • 4.4.1: APAC Market by Product: Reagents and Equipment
  • 4.4.2: APAC Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others
• 4.5: ROW Transfection Reagent and Equipment Market
  • 4.5.1: ROW Market by Product: Reagents and Equipment
  • 4.5.2: ROW Market by End Use: Academics & Research Institutes, Pharmaceutical & Biotechnology Companies, and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Product
  • 6.1.2: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Method
  • 6.1.3: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Application
  • 6.1.4: Growth Opportunities for the Global Transfection Reagent and Equipment Market by End Use
  • 6.1.5: Growth Opportunities for the Global Transfection Reagent and Equipment Market by Region
• 6.2: Emerging Trends in the Global Transfection Reagent and Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Transfection Reagent and Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Transfection Reagent and Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: PromoCell
• 7.2: OriGene Technologies
• 7.3: Thermos Fisher Scientific
• 7.4: Merck
• 7.5: Bio-Rad Laboratories
• 7.6: Lonza
• 7.7: Qiagen N.V.
• 7.8: Mirus Bio
• 7.9: Promega Corporation
• 7.10: F. Hoffmann-La Roche